Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definition
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Rising pet ownership and humanization of pets
3.2.1.2    Increased awareness of skin disorders and advanced treatment options
3.2.2    Industry pitfalls and challenges
3.2.2.1    Side effects of few medications
3.2.2.2    Off-label use of human drugs
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Porter’s analysis
3.6    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company matrix analysis
4.3    Competitive analysis of major market players
4.4    Competitive positioning matrix
4.5    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Glucocorticoids
5.3    Antihistamines
5.4    Immunosuppressants
5.5    mAbs
5.6    Other products
Chapter 6   Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Oral
6.3    Topical
6.4    Injectable
Chapter 7   Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Retail pharmacies
7.3    Veterinary hospital pharmacies
7.4    Online pharmacies
Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    North America
8.2.1    U.S.
8.2.2    Canada
8.3    Europe
8.3.1    Germany
8.3.2    UK
8.3.3    France
8.3.4    Italy
8.3.5    Spain
8.3.6    Netherlands
8.4    Asia Pacific
8.4.1    China
8.4.2    Japan
8.4.3    India
8.4.4    Australia
8.4.5    South Korea
8.5    Latin America
8.5.1    Brazil
8.5.2    Mexico
8.5.3    Argentina
8.6    Middle East and Africa
8.6.1    South Africa
8.6.2    Saudi Arabia
8.6.3    UAE
Chapter 9   Company Profiles
9.1    AB Science
9.2    Boehringer Ingelheim
9.3    Ceva
9.4    Dechra Veterinary Products
9.5    Elanco
9.6    Kindred Biosciences
9.7    Nextmune (Vimian)
9.8    Phibro Animal Health Corporation
9.9    Toray Industries
9.10    Vetoquinol
9.11    Virbac
9.12    Zoetis